Arvinas

New Haven Connecticut United States; Connecticut United States; United States
investor type
Venture Capital
stage focus
Later stage VC, PE Growth/Expansion
Arvinas Inc is a United States-based private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary Proteolysis-Targeting Chimera...
Show more
Relevant investments:
Company
Cost
Round
  • Super company
    Billion
  • Foundersuite
    Million
    Seed A
  • Active Inv
    13 000
    Round Best
Show more